Modular targeted liposomal delivery system

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S001210, C424S009321, C424S009510, C424S417000

Reexamination Certificate

active

07060291

ABSTRACT:
A liposome including a fusogenic liposome, a linking moiety and a targeting moiety. The fusogenic liposome is a lipid bilayer encapsulating contents. The linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety. The liposome may also include a stabilizing moiety interposed between the linking and targeting moieties, and covalently bound to both. Alternatively, the stabilizing and targeting moieties may be covalently bound to separate linking moieties, the linking moieties being electrostatically bound to the lipid bilayer.

REFERENCES:
patent: 5534259 (1996-07-01), Zalipsky et al.
patent: 5935599 (1999-08-01), Dadey
patent: 6287857 (2001-09-01), O'Riordan et al.
Huang, A. et al., “Monoclonal Antibody Covalenty Coupled With Fatty Acid”, The Journal of Biological Chemistry, Sep. 10, vol. 255, No. 17, pp. 8015-8018.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modular targeted liposomal delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modular targeted liposomal delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modular targeted liposomal delivery system will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3669824

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.